Oprazid
Brand Name: Oprazid
Generic Name: Lansoprazole
Active
Registration Number
DRP-3544-02
Dosage Form
Capsule
Issuance Date
April 1, 2022
Expiry Date
May 4, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength30 mg
Packaging18
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Proton Pump Inhibitor
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
LansoprazoleActive
Monograph: Lansoprazole